Income Statement
Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
|||
| Income Statement [Abstract] | ||||||
| Sales (Note 8) | $ 8,974,063 | $ 62,738,544 | $ 37,470,425 | $ 67,502,779 | ||
| Cost of goods sold | 5,433,145 | 37,630,423 | 21,890,044 | 40,448,336 | ||
| Gross profit | 3,540,918 | 25,108,121 | 15,580,381 | 27,054,443 | ||
| Expenses | ||||||
| Advertising and promotion | 130,201 | 320,900 | 358,576 | 865,952 | ||
| Amortization of intangible assets (Note 6) | 389,675 | 219,781 | 779,336 | 438,734 | ||
| Consulting fees, technical support, and commissions | 2,834,170 | 6,487,001 | 8,344,181 | 9,379,871 | ||
| Depreciation (Note 5) | 49,208 | 13,937 | 96,650 | 23,381 | ||
| Foreign exchange loss (gain) | 207,488 | 170,632 | 44,536 | 421,474 | ||
| Office and miscellaneous | 278,914 | 556,509 | 935,922 | 1,050,155 | ||
| Operating lease expense (Note 18) | 118,038 | 103,329 | 248,167 | 205,791 | ||
| Professional fees | 279,519 | 371,771 | 892,635 | 682,457 | ||
| Research and development | 4,368 | 4,368 | ||||
| Salaries and wage expenses | 1,119,887 | 1,434,060 | 3,322,274 | 2,351,596 | ||
| Transfer agent and filing fees | 71,450 | 21,700 | 140,765 | 129,938 | ||
| Travel and accommodation | 109,988 | 674,551 | 172,570 | 1,333,568 | ||
| Warranty and related (Note 11) | 383,414 | 1,226,087 | 1,247,295 | 1,354,791 | ||
| Total expenses | 5,976,320 | 11,600,258 | 16,587,275 | 18,237,708 | ||
| (Loss) income before other income (expenses) | (2,435,402) | 13,507,863 | (1,006,894) | 8,816,735 | ||
| Other income (expenses) | ||||||
| Gain on de-consolidation of subsidiary (Note 17) | 239,174 | 239,174 | ||||
| Gain (loss) on change in fair value of derivative liability (Note 9) | 58,380 | 65,547 | 49,563 | (71,407) | ||
| Gain on reduction of acquisition costs of subsidiary (Note 7) | 3,240,250 | 3,240,250 | ||||
| Financing interest income | 243,575 | 14,668 | 301,290 | 29,636 | ||
| Interest expense | (33,741) | (2,005) | (22,465) | (3,505) | ||
| Provision for loan | 4,754 | 4,754 | ||||
| Gain on termination of lease | 3,019 | 3,019 | ||||
| Total other income (expense) | 3,755,411 | 78,210 | 3,815,585 | (45,276) | ||
| Net income for the period | 1,320,009 | 13,586,073 | 2,808,691 | 8,771,459 | ||
| Other comprehensive income | ||||||
| Foreign currency translation gain | 139,842 | 384,328 | 84,044 | 463,543 | ||
| Comprehensive income for the period | $ 1,459,851 | $ 13,970,401 | $ 2,892,735 | $ 9,235,002 | ||
| Net income per share, basic and diluted (in Dollars per share) | $ 0.03 | $ 0.30 | $ 0.06 | $ 0.19 | ||
| Weight average number of common shares outstanding, basic (in Shares) | [1] | 46,102,259 | 46,030,439 | 46,037,720 | 46,030,439 | |
| Weight average number of dilutive shares outstanding, diluted (in Shares) | 46,254,406 | 46,030,439 | 46,204,757 | 46,030,439 | ||
| ||||||
| X | ||||||||||
- Definition A fee charged for consulting, technical support, and commissions during the reporting period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Gain on reduction of acquisition costs of subsidiary. No definition available.
|
| X | ||||||||||
- Definition Interest income on finance lease. No definition available.
|
| X | ||||||||||
- Definition The cost of office and miscellaneous expenses that was charged against earnings during the period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The costs for filing fees of all financial information as well as corporate communication incurred during the reporting period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of operating lease expense. Excludes sublease income. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Expenses incurred for travel and entertainment during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|